Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 572.5K | -- | 3.25% | +536.6K | 2026-06-30 |
| Vanguard Capital Management LLC | 543.1K | -- | 3.09% | +299.4K | 2026-06-30 |
| Citadel Advisors LLC | 198.5K | -- | 1.13% | +186.7K | 2026-06-30 |
| MAI Capital Management | 108.3K | -- | 0.62% | +17.0K | 2026-06-30 |
| Geode Capital Management, LLC | 88.2K | -- | 0.50% | +2.9K | 2026-06-30 |
| Commonwealth Equity Services, LLC | 51.4K | -- | 0.29% | -- | 2026-06-30 |
| Hrt Financial LP | 51.2K | -- | 0.29% | +39.6K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 49.0K | -- | 0.28% | -- | 2026-06-30 |
| BlackRock, Inc. | 43.3K | -- | 0.25% | -- | 2026-06-30 |
| Bank of America Corp | 40.9K | -- | 0.23% | -81 | 2026-06-30 |
